20p12.3 microdeletion syndrome

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

20q12.3 is a microdeletion syndrome is a chromosome abnormality where a segment of genetic material on chromosome 20 at position 12.3 is deleted.

Common symptoms

Abnormal facial features (HypertelorismDownslanted palpebral fissuresEpicanthusHypoplasia of the maxillaMacrocephalyNarrow mouth) and Wolff-Parkinson-White syndrome

When to suspect

  • Recommendation 1

    Revealed by special techniques such as FISH or microarrays (array-CGH)

How to test

  • Recommendation 1

    Revealed by special techniques such as FISH or microarrays (array-CGH)

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Supportive Treatment Only

Primary care

  • Recommendation 1

    Appropriate referral and management of acute symptoms

Further support

  • Recommendation 1

    No specific physicians specialize in this condition but NORD recommends various rare disease clinics. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health.

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 20p12.3 microdeletion syndrome?

Follow to receive regular updates to the latest research development on this disease via email newsletter.